journal article·2024-12

NIR-activated Janus nanomotors with promoted tumor permeability for synergistic photo-immunotherapy

Yingying Zhang, Yujuan Xing, Hong Zhou, Enhui Ma, Wenbei Xu, Xinran Zhang, Canran Jiang, Shuo Ye, Yanjia Deng, Hong Wang, Jingjing Li, Shaohui Zheng

Acta Biomaterialia· Volume 190
Publisher page

Abstract

Nanoparticle-based photo-immunotherapy has become an attractive strategy to eliminate tumors and activate host immune responses. However, the therapeutic efficacy is heavily restricted by low tumoral penetration and immunosuppressive tumor microenvironment (TME). Herein, near infrared laser (NIR)-propelled Janus nanomotors were presented for deep tumoral penetration, photothermal tumor ablation and photothermal-triggered augmented immunotherapy. The Janus nanomotors (AuNR/PMO@CPG) were constructed with gold nanorods (AuNR) and periodic mesoporous organo-silica nanospheres (PMO), followed by loading of immune adjuvant (CPG ODNs). Under NIR irradiation, the nanomotors exhibited superior photothermal effect, which produced active motion with a speed of 19.3 µm/s for deep tumor penetration and accumulation in vivo. Moreover, the good photothermal heating also benefited effective photothermal ablation to trigger immunogenic cell death (ICD). Subsequently, the ICD effect promoted the release of tumor-associated antigens (TAAs) and damage associated molecular patterns (DAMPs), and further generated abundant tumor vaccines in situ for reprograming the immunosuppressive TME in combination with CPG ODNs to inhibit tumor growth. As a result, a notable in vivo synergistic therapeutic effect was realized on CT26-bearing mice by combining photothermal therapy-induced ICD with modulation of immunosuppressive TME. Thus, we believe that the synthesized nanomotors can provide a new inspect to boost photothermal therapy-induced ICD in tumor immunotherapy. STATEMENT OF SIGNIFICANCE: Nanoparticle-based synergistic photo-immunotherapy has become a popular strategy to eliminate tumors and activate host immune responses. However, the therapeutic efficacy is heavily restricted by low tumoral penetration and immunosuppressive tumor microenvironment (TME). In this work, near infrared laser (NIR)-propelled Janus nanomotors were presented for deep tumoral penetration, photothermal tumor ablation and photothermal-triggered augmented immunotherapy. Under NIR irradiation, the nanomotors exhibited a superior photothermal effect, which produced active motion for deep tumor penetration and accumulation in vivo. Moreover, good photothermal heating also facilitated effective photothermal ablation to trigger immunogenic cell death (ICD), which promoted the release of tumor-associated antigens and damage-associated molecular patterns (DAMPs), and further generated abundant tumor vaccines in situ for reprograming the immunosuppressive TME to inhibit tumor growth.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Micro and Nano Robotics · Molecular Communication and Nanonetworks

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment10.1186/s12943-023-01761-7 ↗
2. Express delivery of next-generation CAR T cells with preserved naive and stemness phenotypes for the treatment of aggressive lymphomas10.1158/2159-8290.CD-23-0735 ↗
3. Biomaterial-based in situ cancer vaccines
4. Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy10.1038/s41467-023-42155-z ↗
5. Engineering patient-specific cancer immunotherapies10.1038/s41551-019-0436-x ↗
6. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy10.1038/s41577-021-00547-6 ↗
7. Economic evaluation of chimeric antigen receptor T-cell therapy by site of care among patients with relapsed or refractory large B-cell lymphoma10.1001/jamanetworkopen.2020.2072 ↗
8. GPRC5D-targeted CAR T cells for myeloma10.1056/NEJMoa2209900 ↗
9. Targeting inflamed and non-inflamed melanomas: biological background and clinical challenges10.1016/j.semcancer.2022.06.005 ↗
10. Self-assembled immunostimulatory tetrahedral framework nucleic acid vehicles for tumor chemo-immunotherapy10.1021/acsami.2c09462 ↗
11. Corn-like Au/Ag nanorod-mediated NIR-II photothermal/photodynamic therapy potentiates immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment10.1016/j.biomaterials.2020.120582 ↗
12. Dying cells actively regulate adaptive immune responses10.1038/nri.2017.9 ↗
13. Manganese-enriched zinc peroxide functional nanoparticles for potentiating cancer immunotherapy10.1021/acs.nanolett.3c02941 ↗
14. Renal clearable ultrasmall single-crystal fe nanoparticles for highly selective and effective ferroptosis therapy and immunotherapy10.1021/jacs.1c07471 ↗
15. Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer10.1016/j.apsb.2022.11.018 ↗
16. Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency10.1002/advs.202201734 ↗
17. Hypoxia-responsive immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy for potentiating cancer immunotherapy10.1016/j.cej.2022.138781 ↗
18. Tailoring multifunctional small molecular photosensitizers to in vivo self-assemble with albumin to boost tumor-preferential accumulation, NIR imaging, and photodynamic/photothermal/immunotherapy
19. Reduction-triggered polycyclodextrin supramolecular nanocage induces immunogenic cell death for improved chemotherapy10.1016/j.carbpol.2022.120365 ↗
20. Aggregation-induced-emission photosensitizer-loaded nano-superartificial dendritic cells with directly presenting tumor antigens and reversed immunosuppression for photodynamically boosted immunotherapy10.1002/adma.202208555 ↗
21. Dynamic adjust of non-radiative and radiative attenuation of aie molecules reinforces NIR-II imaging mediated photothermal therapy and immunotherapy10.1002/advs.202104793 ↗
22. A three-in-one assembled nanoparticle containing peptide-radio-sensitizer conjugate and TLR7/8 agonist can initiate the cancer-immunity cycle to trigger antitumor immune response10.1002/smll.202107001 ↗
23. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
24. Glutathione-depleting organic metal adjuvants for effective NIR-II photothermal immunotherapy10.1002/adma.202201706 ↗
25. In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors10.1016/j.biomaterials.2022.121808 ↗
26. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect10.1016/j.biomaterials.2023.122434 ↗
27. NIR-triggerable ROS-responsive cluster-bomb-like nanoplatform for enhanced tumor penetration, phototherapy efficiency and antitumor immunity10.1016/j.biomaterials.2021.121135 ↗
28. Nanomotors sense local physicochemical heterogeneities in tumor microenvironments**10.1002/anie.202008681 ↗
29. Oral nanomotor-enabled mucus traverse and tumor penetration for targeted chemo-sono-immunotherapy against colon cancer10.1002/smll.202203466 ↗
30. Photoactivated organic nanomachines for programmable enhancement of antitumor efficacy10.1002/smll.202201525 ↗
31. Nanosized Janus AuNR-Pt motor for enhancing NIR-II photoacoustic imaging of deep tumor and Pt2+ ion-based chemotherapy10.1021/acsnano.2c00732 ↗
32. Bladder microenvironment actuated proteomotors with ammonia amplification for enhanced cancer treatment10.1016/j.apsb.2023.02.016 ↗
33. Controlled propulsion of micro/nanomotors: operational mechanisms, motion manipulation and potential biomedical applications10.1039/D2CS00432A ↗
34. NIR-actuated targeted Janus nanomotors remodel immunosuppressive tumor microenvironment for augmented cancer immunotherapy10.1002/adhm.202302272 ↗
35. NIR-II light-actuated nanomotors for enhanced photoimmunotherapy toward hepatocellular carcinoma10.1021/acsami.4c06994 ↗
36. Dual-driven nanomotors enable tumor penetration and hypoxia alleviation for calcium overload-photo-immunotherapy against colorectal cancer10.1016/j.biomaterials.2023.122332 ↗
37. Synthesis of Janus Au@periodic mesoporous organosilica (PMO) nanostructures with precisely controllable morphology: a seed-shape defined growth mechanism10.1039/C7NR01047H ↗
38. Photothermal nanofibres enable safe engineering of therapeutic cells10.1038/s41565-021-00976-3 ↗
39. A facile strategy of boosting photothermal conversion efficiency through state transformation for cancer therapy10.1002/adma.202105999 ↗
40. Multifunctional parachute-like nanomotors for enhanced skin penetration and synergistic antifungal therapy10.1021/acsnano.1c01379 ↗